The measurement of human serum ceruloplasmin remains an indispensable tool in hepatology and neurology. While automated immunological assays provide speed and consistency, the biological complexity of the protein requires clinicians to correlate laboratory data with patient symptoms and, occasionally, functional enzymatic studies. Understanding these nuances ensures accurate diagnosis and effective management of copper-related metabolic disorders.

Is there a specific (like the Mayo Clinic or WHO) you are trying to reference?

These are the most common methods in modern clinical labs. They use specific antibodies that bind to the ceruloplasmin protein, creating complexes that scatter light. The degree of light scatter is proportional to the protein concentration.